Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
Savor (SVR) / FY26

Savor swung to $1.8m PBT with EBITDA margin at 14.5%

Operating margin moved above its 9.8%-14.2% five-year range as revenue softened and capex rose 69%, with PBT the cleaner read on the result.

Consumer / Hospitality

SVR revenue trajectory

Revenue context before the current result.

↗
Loading chart...
FY26 was $55.2m, versus $56.6m in FY25.

SVR EBITDA margin

EBITDA margin across covered periods.

↗
Loading chart...
  • HY22 SVR: Outside range high ebitda margin. 12.3%; 3-period range 6.8% to 10.7%. EBITDA margin: 12.3%, above normal range; 3-period mean 8.1%, range 6.8%-10.7%.
  • FY22 SVR: Outside range low ebitda margin. 9.8%; 5-period range 10% to 14.5%. EBITDA margin: 9.8%, below normal range; 5-period mean 12.4%, range 10.0%-14.5%.
  • HY23 SVR: Outside range low ebitda margin. 6.8%; 3-period range 6.9% to 12.3%. EBITDA margin: 6.8%, below normal range; 3-period mean 10.0%, range 6.9%-12.3%.
  • FY26 SVR: Outside range high ebitda margin. 14.5%; 5-period range 9.8% to 14.2%. EBITDA margin: 14.5%, above normal range; 5-period mean 11.5%, range 9.8%-14.2%.
EBITDA margin: 14.5%, above normal range; 5-period mean 11.5%, range 9.8%-14.2%.

SVR operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
FY26 was $6.9m, versus $7.1m in FY25.

SVR working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
  • HY21 SVR: Outside range low operating working-capital movement. $-8m; 3-period range $-1m to $0.2m. Operating working-capital movement: NZ$-8.0m, below normal range; 1/3 prior periods had builds averaging NZ$0.2m, and 1 had releases averaging NZ$-1.0m.
  • FY22 SVR: Outside range high operating working-capital movement. $0.2m; 5-period range $-3.4m to $0.1m. Operating working-capital movement: NZ$0.2m, above normal range; 1/5 prior periods had builds averaging NZ$0.1m, and 4 had releases averaging NZ$-1.8m.
  • FY23 SVR: Unprecedented low operating working-capital movement. $-3.4m; 5-period range $-3.1m to $0.2m. Operating working-capital movement: NZ$-3.4m, unprecedented low; 2/5 prior periods had builds averaging NZ$0.2m, and 3 had releases averaging NZ$-1.2m.
  • HY24 SVR: Outside range high operating working-capital movement. $0.2m; 3-period range $-8m to $0m. Operating working-capital movement: NZ$0.2m, above normal range; 0/3 prior periods had builds, and 2 had releases averaging NZ$-4.5m.
Operating working-capital movement: NZ$0.2m, above normal range; 0/3 prior periods had builds, and 2 had releases averaging NZ$-4.5m.
Release date
26 May 2026
Published
26 May 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

FY26 vs FY25

Revenue

$55.2m

-2.6% ↓ vs $56.6m

EBITDA

$8m

+10.3% ↑ vs $7.3m

Net profit after tax

$1.3m

+208.3% ↑ vs −$1.2m

Net cash inflow from operating activities

$6.9m

-3.2% ↓ vs $7.1m

Profit before tax

$1.8m

+228.6% ↑ vs −$1.4m

Total assets

$49.6m

-3.9% ↓ vs $51.6m

What changed

Savor returned to profit in FY26, reporting PBT of $1.8m versus a $1.4m loss in FY25 and NPAT of $1.3m versus a $1.2m loss

Revenue softened to $55.2m from $56.6m, so the swing was driven by margin rather than top-line growth: EBITDA rose to $8.0m from $7.3m, and EBITDA margin reached 14.5%, just above the 9.8%-14.2% band Annolyse's historical baseline shows over the prior five years.

Cash generation held up: operating cash flow was $6.9m versus $7.1m, and net debt fell to $6.3m from $7.2m, leaving net debt/EBITDA at 0.79x against a historical mean of 2.07x. Capex stepped up to $2.2m from $1.3m, a 69% increase that took capex intensity to 4.1% of revenue from 2.3%.

What matters

Margin reset, not revenue recovery

Operating earnings expanded with revenue down, indicating cost or mix improvement rather than volume recovery. EBITDA margin at 14.5% sits above the supplied historical range, and PBT margin of 3.3% is the first positive reading in the five-year baseline (prior range -19.2% to -2.5%). The durability question is whether this margin level can hold without revenue growth resuming.

Tax line distorts the headline. The current effective tax rate of -27.5% sits well below the historical mean of 27.8%, and the calculation pass flags tax distortion in the result. PBT is therefore the cleaner read on operating performance; the NPAT swing should not be taken as untaxed economic improvement, and the 16.8 percentage-point gap between PBT and NPAT growth is tax-driven rather than operational.

Leverage materially below the historical range. Net debt/EBITDA of 0.79x is below the 1.0x-4.0x band in the historical baseline. Gross borrowings fell to $8.0m from $9.0m and equity rose to $18.7m, which means balance-sheet flexibility has improved materially - relevant given the step-up in capex intensity.

Expectations

No forward targets or guidance are stated in the release, and no forward-work or backlog disclosure is available

Half-year context shows HY26 captured 52.7% of full-year revenue but only 39.2% of EBITDA, implying the second half was margin-stronger on a smaller revenue base - a shape that frames durability questions about the FY26 EBITDA margin reading.

The 69% capex step-up to $2.2m and the rise in capex intensity to 4.1% suggest reinvestment is underway, but the release excerpts do not disclose what is being funded or the expected return profile. Without that, this briefing cannot tie the capex shape to a forward earnings or revenue path.

Quality of result

Cash conversion at 85.8% sits within the historical range and above the five-year mean of 77.2%, so the result is broadly cash-backed

However, OCF fell modestly while EBITDA rose, meaning conversion deteriorated versus the prior comparable even though the absolute level remains healthy. A small working-capital absorption of $0.1m sits at the upper edge of the historical pattern, where prior years typically released around $1.8m of cash, so working capital did not flatter the cash result.

Free cash flow pre-lease was $4.6m versus $5.8m, with the decline explained mostly by higher capex rather than weaker operations. The reported NPAT improvement carries a tax-benefit element that should not be extrapolated, but EBITDA, PBT, and operating cash flow all sit at or near multi-year highs on the supplied baseline, which suggests the underlying step-change is operational rather than accounting-driven. Capex intensity has nearly doubled, so future free-cash-flow conversion will depend on whether the heavier investment cadence persists.

Unresolved

Open questions

What is the $2.2m capex funding, and what return or revenue contribution does management expect from it?
Why did the effective tax rate move outside the historical range, and is that position sustainable into FY27?
How much of the 14.5% EBITDA margin is structural versus tied to specific cost actions taken in FY26?
Will operating cash flow recover toward EBITDA conversion as working-capital absorption normalises, or is the prior pattern of cash releases unlikely to repeat?
Does management view revenue as stabilised at the FY26 level, or is further softening expected before reinvestment lifts the top line?

This briefing cannot assess the operational drivers behind the margin step-up or the strategic intent behind the capex increase because the supplied release excerpts and context do not disclose them.

Chat

Ask about SVR FY26

Ask follow-up questions about Savor's FY26 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about SVR FY26

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Savor's FY26 result.

What is the $2.2m capex funding, and what return or revenue contribution does management expect from it?Why does "Margin reset, not revenue recovery" matter?How strong was the cash and earnings quality in FY26?What should I watch next for SVR after FY26?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Savor Annual Report 2026

FY26 / financial report↗

Savor Annual Results - Market Announcement

FY26 / results release↗

Savor Annual Results - NZX Appendix 2

FY26 / results announcement↗

Prior comparable period

Savor Annual Report 2025

FY25 / financial report↗

Savor Annual Results - Market Announcement

FY25 / results release↗

Savor Annual Results - NZX Appendix 2

FY25 / results announcement↗

Interim context

Savor Interim Financial Statements

HY26 / financial report↗

Savor Interim Results - Appendix 2

HY26 / results announcement↗

Savor Interim Results Announcement

HY26 / results release↗

Release context

Savor 2023 Annual Meeting results

HY26 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Cash conversion quality

This result converted 85.8% of EBITDA to operating cash flow, -11.9pp versus the prior comparable period.

→

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 16.8pp, with a distortion flag in the result.

→

Leverage and balance-sheet risk

Net debt / EBITDA is 0.79x, -0.20x versus the prior comparable period.

→

ROE and capital efficiency

ROE was 6.9%, +13.9pp versus the prior comparable period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when SVR publishes next

Get the next Savor briefing and related NZX reporting-season updates by email.